• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The genetics of Parkinson disease.帕金森病的遗传学。
J Geriatr Psychiatry Neurol. 2010 Dec;23(4):228-42. doi: 10.1177/0891988710383572. Epub 2010 Oct 11.
2
Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?家族性帕金森病基因中的多态性是否会增加散发性帕金森病的发病风险?
Mov Disord. 2009 Apr 30;24(6):833-8. doi: 10.1002/mds.22214.
3
Clinical genetics of Parkinson's disease and related disorders.帕金森病及相关疾病的临床遗传学
Parkinsonism Relat Disord. 2007;13 Suppl 3:S229-32. doi: 10.1016/S1353-8020(08)70007-5.
4
Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2.对来自葡萄牙的帕金森病患者进行SNCA、PRKN、PINK1和LRRK2基因突变分析。
BMC Neurol. 2008 Jan 22;8:1. doi: 10.1186/1471-2377-8-1.
5
Structural genomic variations and Parkinson's disease.结构基因组变异与帕金森病
Minerva Med. 2017 Oct;108(5):438-447. doi: 10.23736/S0026-4806.17.05246-6. Epub 2017 May 25.
6
Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.LRRK2、SNCA、Parkin、PINK1 和 DJ-1 在赞比亚帕金森病患者中的分析。
Parkinsonism Relat Disord. 2012 Jun;18(5):567-71. doi: 10.1016/j.parkreldis.2012.02.018. Epub 2012 Mar 24.
7
Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.帕金森病中五个孟德尔基因及全基因组关联研究中顶级基因的重测序分析。
Mol Neurodegener. 2016 Apr 19;11:29. doi: 10.1186/s13024-016-0097-0.
8
Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations.巴西运动障碍诊所中的家族性帕金森病和早发性帕金森病:SNCA、PRKN、PINK1和LRRK2突变的表型特征及频率
Mov Disord. 2009 Apr 15;24(5):662-6. doi: 10.1002/mds.22365.
9
Genetics of Parkinson disease.帕金森病的遗传学
Handb Clin Neurol. 2018;147:211-227. doi: 10.1016/B978-0-444-63233-3.00014-2.
10
Clinical implications of gene discovery in Parkinson's disease and parkinsonism.帕金森病和帕金森综合征基因发现的临床意义。
Mov Disord. 2010;25 Suppl 1:S15-20. doi: 10.1002/mds.22723.

引用本文的文献

1
Nutraceutical Strategies for Targeting Mitochondrial Dysfunction in Neurodegenerative Diseases.针对神经退行性疾病中线粒体功能障碍的营养保健品策略
Foods. 2025 Jun 23;14(13):2193. doi: 10.3390/foods14132193.
2
Sleep Disturbance in Parkinson's Disease: Consequences for the Brain and Disease Progression - A Narrative Review.帕金森病中的睡眠障碍:对大脑和疾病进展的影响——一篇叙述性综述
Nat Sci Sleep. 2025 Jun 28;17:1521-1537. doi: 10.2147/NSS.S478860. eCollection 2025.
3
Parkinson's disease: exploring the systemic immune mechanisms through molecular investigations.帕金森病:通过分子研究探索全身免疫机制
Inflammopharmacology. 2025 Jun 23. doi: 10.1007/s10787-025-01816-9.
4
Potential common pathogenesis of several neurodegenerative diseases.几种神经退行性疾病潜在的共同发病机制。
Neural Regen Res. 2026 Mar 1;21(3):972-988. doi: 10.4103/NRR.NRR-D-24-01054. Epub 2025 May 30.
5
Associations Between Diabetes Mellitus and Neurodegenerative Diseases.糖尿病与神经退行性疾病之间的关联。
Int J Mol Sci. 2025 Jan 10;26(2):542. doi: 10.3390/ijms26020542.
6
Unravelling the Role of Tyrosine and Tyrosine Hydroxylase in Parkinson's Disease: Exploring Nanoparticle-based Gene Therapies.解析酪氨酸和酪氨酸羟化酶在帕金森病中的作用:探索基于纳米颗粒的基因疗法。
CNS Neurol Disord Drug Targets. 2025;24(5):325-339. doi: 10.2174/0118715273336139241211071748.
7
Therapeutic Role of Scutellarein in Neurological Disorders.黄芩素在神经系统疾病中的治疗作用
Curr Pharm Des. 2025;31(20):1583-1592. doi: 10.2174/0113816128336901241125092132.
8
Nanotechnology and CRISPR/Cas-Mediated Gene Therapy Strategies: Potential Role for Treating Genetic Disorders.纳米技术与CRISPR/Cas介导的基因治疗策略:治疗遗传疾病的潜在作用。
Mol Biotechnol. 2024 Oct 24. doi: 10.1007/s12033-024-01301-8.
9
Non-motor symptoms of Parkinson`s disease-insights from genetics.帕金森病的非运动症状——来自遗传学的启示。
J Neural Transm (Vienna). 2024 Nov;131(11):1277-1284. doi: 10.1007/s00702-024-02833-8. Epub 2024 Sep 19.
10
Parkinson's Disease Gene Screening in Familial Cases from Central and South America.中美洲和南美洲家族性帕金森病基因筛查。
Mov Disord. 2024 Oct;39(10):1843-1855. doi: 10.1002/mds.29931. Epub 2024 Jul 25.

本文引用的文献

1
Common variation in the LRRK2 gene is a risk factor for Parkinson's disease.LRRK2 基因的常见变异是帕金森病的风险因素。
Mov Disord. 2012 Dec;27(14):1822-5. doi: 10.1002/mds.25226. Epub 2012 Oct 31.
2
A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.对 PARK2 中的缺失、重复和拷贝数变异进行全面分析。
Neurology. 2010 Sep 28;75(13):1189-94. doi: 10.1212/WNL.0b013e3181f4d832.
3
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease.常见的 HLA 区域内的遗传变异与晚发性散发性帕金森病有关。
Nat Genet. 2010 Sep;42(9):781-5. doi: 10.1038/ng.642. Epub 2010 Aug 15.
4
The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders.葡萄糖脑苷脂酶突变在帕金森病和路易体障碍中的作用。
Curr Neurol Neurosci Rep. 2010 May;10(3):190-8. doi: 10.1007/s11910-010-0102-x.
5
Imaging approaches to Parkinson disease.帕金森病的影像学方法。
J Nucl Med. 2010 Apr;51(4):596-609. doi: 10.2967/jnumed.108.059998.
6
Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.全基因组关联研究证实,α-突触核蛋白基因(SNCA)和微管相关蛋白tau基因(MAPT)区域的单核苷酸多态性(SNPs)是帕金森病的常见风险因素。
Ann Hum Genet. 2010 Mar;74(2):97-109. doi: 10.1111/j.1469-1809.2009.00560.x. Epub 2010 Jan 8.
7
Immunohistochemical and proteomic evaluation of nuclear ubiquitous casein and cyclin-dependent kinases substrate in invasive ductal carcinoma of the breast.乳腺浸润性导管癌中核普遍存在的酪蛋白和细胞周期蛋白依赖性激酶底物的免疫组织化学和蛋白质组学评估
J Biomed Biotechnol. 2009;2009:919645. doi: 10.1155/2009/919645. Epub 2009 Dec 24.
8
Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein.富含亮氨酸重复激酶 2 调节帕金森病相关突变型 α-突触核蛋白诱导的神经病理学进展。
Neuron. 2009 Dec 24;64(6):807-27. doi: 10.1016/j.neuron.2009.11.006.
9
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease.全基因组关联研究确定了四个位点的常见变异为帕金森病的遗传风险因素。
Nat Genet. 2009 Dec;41(12):1303-7. doi: 10.1038/ng.485. Epub 2009 Nov 15.
10
Genome-wide association study reveals genetic risk underlying Parkinson's disease.全基因组关联研究揭示帕金森病的遗传风险。
Nat Genet. 2009 Dec;41(12):1308-12. doi: 10.1038/ng.487. Epub 2009 Nov 15.

帕金森病的遗传学。

The genetics of Parkinson disease.

机构信息

Geriatric Research, Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA.

出版信息

J Geriatr Psychiatry Neurol. 2010 Dec;23(4):228-42. doi: 10.1177/0891988710383572. Epub 2010 Oct 11.

DOI:10.1177/0891988710383572
PMID:20938043
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3044594/
Abstract

Parkinson disease (PD) is the second most common neurodegenerative disorder. In most instances, PD is thought to result from a complex interaction between multiple genetic and environmental factors, though rare monogenic forms of the disease do exist. Mutations in 6 genes (SNCA, LRRK2, PRKN, DJ1, PINK1, and ATP13A2) have conclusively been shown to cause familial parkinsonism. In addition, common variation in 3 genes (MAPT, LRRK2, and SNCA) and loss-of-function mutations in GBA have been well-validated as susceptibility factors for PD. The function of these genes and their contribution to PD pathogenesis remain to be fully elucidated. The prevalence, incidence, clinical manifestations, and genetic components of PD are discussed in this review.

摘要

帕金森病(PD)是第二常见的神经退行性疾病。大多数情况下,PD 被认为是由多种遗传和环境因素的复杂相互作用引起的,尽管确实存在罕见的单基因形式的疾病。6 个基因(SNCA、LRRK2、PRKN、DJ1、PINK1 和 ATP13A2)的突变已被明确证实可导致家族性帕金森病。此外,3 个基因(MAPT、LRRK2 和 SNCA)的常见变异和 GBA 的功能丧失突变已被充分验证为 PD 的易感因素。这些基因的功能及其对 PD 发病机制的贡献仍有待充分阐明。本文综述了 PD 的患病率、发病率、临床表现和遗传成分。